EPAS1 and breast cancer: It has also been reported that high USP5 expression in breast cancer leads to poor clinical prognosis, and its molecular mechanism is related to the promotion of breast cancer cell proliferation, migration, and invasion by stabilizing the HIF2α protein through deubiquitination activity (56).